siRNA silencing of SOX10 may contribute to the G1 phase arrest of melanoma cells via inhibiting the expression of cyclin/cyclin-dependent kinases (CDK) complex, suggesting the antineoplastic effects of SOX10 knockdown (Shakhova et al., 2012). This evidence concerns the gene SOX10 and melanoma.